Browsing by Author "Rabindra Kumar Jena"

Now showing 1 - 2 of 2

Indian Society of Hematology and Blood Transfusion (ISHBT) Consensus Document on Hematological Practice During COVID-19 Pandemic
(Springer, 2021) Rakhee Kar; Tuphan Kanti Dolai; Prakash Singh Shekhawat; Pankaj Malhotra; Avinash Singh; Rahul Naithani; Prakas Kumar Mandal; Prasanth Ganesan; Prabhu Manivannan; Debdatta Basu; Alok Srivastava; Reena Das; Maitreyee Bhattacharya; Manoranjan Mahapatra; Rishi Dhawan; Arihant Jain; Chandni Bhandary; Hara Prasad Pati; Tathagata Chatterjee; Vijai Tilak; Sarmila Chandra; Shrimati Dharampal Shetty; Rabindra Kumar Jena
The SARS-CoV-2 (COVID-19) pandemic is a worldwide public health emergency with widespread impact on health care delivery. Unforeseen challenges have been noted during administration of usual haematology care in these unusual COVID-19 times. Medical services have been overstretched and frontline health workers have borne the brunt of COVID-19 pandemic. Movement restrictions during lockdown prevented large sections of population from accessing health care, blood banks from holding blood drives, and disrupted delivery of diagnostic hematology services. The disruption in hematology care due to COVID-19 pandemic in India has been disproportionately higher compared to other subspecialities as hematology practice in India remains restricted to major cities. In this review we chronicle the challenges encountered in caring for hematology patients during the COVID-19 pandemic in India and put forth recommendations for minimizing their impact on provision of hematology care with special emphasis on hematology practice in lower and middle income countries (LMICs). © 2021, Indian Society of Hematology and Blood Transfusion.
Unmet Needs in Hemophilia: A Narrative Review
(Journal of Association of Physicians of India, 2025) Rabindra Kumar Jena; Tuphan Kanti Dolai; Jina Bhattacharyya; Kapil Garg; Sudha Sethy; Subhash C. Jha; Lalit Prashant Meena; Meera Varadarajan; Damodar Das; Nehal Patel; Anil I. Singh; Ramnath P. Nevrekar
This review assesses the current landscape of hemophilia management, focusing on identifying unmet clinical needs. Hemophilia, a rare genetic bleeding disorder, requires continuous and comprehensive care to improve patients’ life expectancy and quality of life (QoL). Despite advancements in treatment, challenges persist, including suboptimal bleed protection with current prophylactic options, the development of inhibitory alloantibodies, and the resulting joint damage leading to hemophilic arthropathy (HA). Additionally, the review highlights the significant physical and psychological burden on patients, impacting their education, employment, and overall QoL. Addressing these unmet needs through innovative therapies, improved access to care, and individualized treatment strategies is crucial for enhancing outcomes and reducing the overall burden of hemophilia, particularly in high-prevalence regions like India. © The Author(s). 2025.